Early decrease of
serum biomarkers of type II collagen degradation (Coll2-1) and joint
inflammation (Coll2-1 NO2 ) by hyaluronic acid intra-articular injections in
patients with knee osteoarthritis: A research study part of the Biovisco study
Henrotin
Y, Chevalier X, Deberg M, Balblanc JC, Richette P, Mulleman D, Maillet B,
Rannou F, Piroth C, Mathieu P, Conrozier T; Osteoarthritis Group of the French
Society of Rheumatology. J Orthop Res.
2013 Jun;31(6):901-7. doi: 10.1002/jor.22297. Epub 2013 Feb 19.
Take Home Message: Hyaluronic acid injections decrease factors
related to collagen degradation. Some blood tests may differentiate responders
and nonresponders to these injections.
Knee
osteoarthritis, one of the leading causes of disability, has no cure and
current treatments commonly involve medications to decrease inflammation and
pain. Hyaluronic acid (HA) injections
have become a popular form of treatment for knee osteoarthritis. However, the mechanism of action has yet to
be determined. Therefore, the authors
examined serum biomarkers of collagen breakdown (Coll2-1 and Coll2-1 NO2)
in 45 patients with various stages of knee osteoarthritis before (-15 days), at
the time of injection, and following treatment (30 and 90 days) with HA
injections.